An FDA committee will discuss emergency use authorization of the coronavirus disease 2019 (COVID-19) vaccine from Johnson & Johnson (J&J); American Cancer Society issues a report on cancer survivor concerns; Tennessee is found to have wasted thousands of vaccine doses.
On Friday, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene to discuss issuing an emergency use authorization for Johnson & Johnson’s coronavirus disease 2019 (COVID-19) vaccine. Officials from Janssen, the Center for Biologics Evaluation and Research, and the CDC will present phase 3 trial data on the single-dose vaccine’s effectiveness against both common strains and newly emerging variants. The vaccine has demonstrated 86% and 82% effectiveness against severe COVID-19 cases in the United States and South Africa, respectively, with overall effectiveness rates of 72% and 64%, reports The New York Times.
Treatment and care disruptions, affordability, and social isolation are just some of the main concerns of cancer survivors, according to a new American Cancer Society (ACS) report released today in Journal of Psychosocial Oncology. COVID-19’s impact on the risk of intensive care unit admission and death was the No. 1 concern for 77% of the 972 respondents to the ACS’ Cancer Action Network’s Survivor Views Panel Study. The amount of interrupted care highlights the need for policy intervention improvements and new health care delivery models that address patient safety and their financial concerns, the authors note.
A recent investigation by Tennessee’s Department of Health (DOH) reveals widespread issues, including spoiled doses and poor record-keeping, in that state’s COVID-19 vaccine distribution, according to The Associated Press. More than 2400 doses were found to have gone unused in Shelby County (the state’s largest) alone in February, with the DOH report blaming recent winter storms for the tossing of 1000 of these doses. Local officials also reportedly sat on tens of thousands of additional shots. Going forward, vaccine distribution will be handled by hospital partners and city officials of Memphis, which is in Shelby County.
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies
August 13th 2025The treatment of pediatric obstructive sleep apnea syndrome is moving toward a personalized, multidisciplinary approach that combines surgical options with a growing number of nonsurgical alternatives, to better address the unique needs of each child.
Read More
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries
August 4th 2025Despite their devastating global impact, chronic respiratory diseases remain a hidden threat in low- and middle-income countries, often going undiagnosed in adults who are already battling other noncommunicable diseases.
Read More
RSV's Impact on Heart Health Emphasizes Broader Risks, Vaccination Importance for Older Adults
July 23rd 2025Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in older adults, underscoring the need for vaccination in this population regardless of their preexisting health conditions.
Read More